

Theory & Insights, the Impact of Articificial Intelligence & Large Language Models on Pharma | Executive Dose
Jul 31, 2025
In this engaging discussion, John Nosta, an AI and technology theorist and founder of NostaLab, joins Stephen Beckman, CEO of YARAL Pharma. They explore how AI and Large Language Models are revolutionizing pharmaceutical manufacturing and healthcare. Topics include the balance between innovation and ethics, the philosophical implications of AI on human creativity, and the evolving roles of healthcare professionals. They emphasize the necessity of human-AI collaboration and a patient-centered approach in shaping the future of medicine.
AI Snips
Chapters
Books
Transcript
Episode notes
LLMs Unlock Thought Not Just Facts
- Large language models unlock 'thought' by enabling iterative dialogues that advance human thinking.
- John Nosta argues this creates a new cognitive partnership rather than simple fact lookup.
Innovation Expands Opportunities
- Innovation expands opportunity rather than simply replacing human roles.
- Nosta uses photography, chess, and Jeopardy to show human roles persist and evolve after automation.
Engage AI As A Process Not A Product
- Treat AI as a process to engage, not a single 'killer app' you plug in.
- John Nosta recommends experiential adoption so teams learn by using AI directly.